Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 26:13:905356.
doi: 10.3389/fimmu.2022.905356. eCollection 2022.

Synovial Macrophages: Past Life, Current Situation, and Application in Inflammatory Arthritis

Lin-Kun Bai  1 , Ya-Zhen Su  1 , Xue-Xue Wang  1 , Bing Bai  2 , Cheng-Qiang Zhang  3 , Li-Yun Zhang  1 , Gai-Lian Zhang  3
Affiliations

Synovial Macrophages: Past Life, Current Situation, and Application in Inflammatory Arthritis

Lin-Kun Bai et al. Front Immunol. .

Abstract

Inflammatory arthritis is an inflammatory disease that involves the joints and surrounding tissues. Synovial hyperplasia often presents when joints become inflamed due to immune cell infiltration. Synovial membrane is an important as well as a highly specific component of the joint, and its lesions can lead to degeneration of the joint surface, causing pain and joint disability or affecting the patients' quality of life in severe cases. Synovial macrophages (SMs) are one of the cellular components of the synovial membrane, which not only retain the function of macrophages to engulf foreign bodies in the joint cavity, but also interact with synovial fibroblasts (SFs), T cells, B cells, and other inflammatory cells to promote the production of a variety of pro-inflammatory cytokines and chemokines, such as TNF-α, IL-1β, IL-8, and IL-6, which are involved in the pathogenic process of inflammatory arthritis. SMs from different tissue sources have differently differentiated potentials and functional expressions. This article provides a summary on studies pertaining to SMs in inflammatory arthritis, and explores their role in its treatment, in order to highlight novel treatment modalities for the disease.

Keywords: arthritis; cell subsets; macrophages; synovial macrophages; synovial membrane; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Synovial structures in inflammatory arthritis. Synovial macrophages are mainly distributed in the lining layer of synovial tissue. During the onset of the disease, SMs can not only induce inflammation, but also perform immune monitoring.
Figure 2
Figure 2
The immunogenic role of synovial macrophages in inflammatory arthritis. Synovial macrophages interact with other immune cells through cytokines, chemokines, and inflammatory mediators to promote the activation, proliferation, and differentiation of lymphocytes, synovial fibroblasts, and osteoclasts in the synovium. TRM, tissue-resident memory T; SM, synovial macrophage; SF, synovial fibroblast; OC, osteoclast; AtoMs, arthritis-associated osteoclastogenic macrophages; IL-1RA, IL-1 receptor antagonists; IL-1βR, IL-1β receptor; IL-12R, IL-12 receptor; IL-23R, IL-23 receptor; IL-1R, IL-1 receptor; IL-6R, IL-6 receptor; IL-33R, IL-33 receptor; CD206L, CD206 ligand; CXCL, C-X-C motif chemokine ligand; CXCR, C-X-C motif chemokine receptor; CCL, C-C motif chemokine ligand; CCR, C-C motif chemokine receptor; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ; OPG, osteoprotegerin; MerTK, tyrosine-protein kinase Mer; IRF5, interferon regulatory factor 5; BCA-1, B-cell-attracting chemokine; BCDF, B-cell differentiation factor; TLR, toll-like receptor; RANK, receptor activator of nuclear factor kappa-B; RANKL, receptor activator of nuclear factor kappa-B ligand; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; PG, prostaglandin.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Jiang P, Song KG. Advances in the Study of Osteoclasts and Their Differentiation Regulatory Mechanisms. Chin J Bone Joint (2017) 6(03):223–7. doi: 10.3969/j.issn.2095-252X.2017.03.013 - DOI
    1. Global Burden of Disease Study 2013 Collaborators . Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. Lancet (2015) 386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 - DOI - PMC - PubMed
    1. Alivernini S, Tolusso B, Petricca L, Bui L, Di Sante G, Peluso G, et al. . Synovial Features of Patients With Rheumatoid Arthritis and Psoriatic Arthritis in Clinical and Ultrasound Remission Differ Under Anti-TNF Therapy: A Clue to Interpret Different Chances of Relapse After Clinical Remission? Ann Rheum Dis (2017) 76(7):1228–36. doi: 10.1136/annrheumdis-2016-210424 - DOI - PMC - PubMed
    1. Dakin SG, Coles M, Sherlock JP, Powrie F, Carr AJ, Buckley CD. Pathogenic Stromal Cells as Therapeutic Targets in Joint Inflammation. Nat Rev Rheumatol (2018) 14(12):714–26. doi: 10.1038/s41584-018-0112-7 - DOI - PubMed
    1. Kurowska-Stolarska M, Alivernini S. Synovial Tissue Macrophages: Friend or Foe? RMD Open (2017) 3(2):e000527. doi: 10.1136/rmdopen-2017-000527 - DOI - PMC - PubMed

Publication types